1-12 of 12
Matija Snuderl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant Astrocytomas

Matthew D. Lee, Rajan Jain, Kristyn Galbraith, Anna Chen, Evan Lieberman, Sohil H. Patel, Dimitris G. Placantonakis, David Zagzag, Marissa Barbaro, Maria del Pilar Guillermo Prieto Eibl, John G. Golfinos, Daniel A. Orringer, Matija Snuderl
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (16): 3512–3519.
https://doi.org/10.1158/1078-0432.CCR-24-0311
Published: 15 August 2024
View article titled, T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and <em>CDKN2A/B</em> Status in <em>IDH</em>-Mutant Astrocytomas
Open the PDF for T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and <em>CDKN2A/B</em> Status in <em>IDH</em>-Mutant Astrocytomas in another window
Includes: Supplementary data
Journal Articles

Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma

Sylvia C. Kurz, Elcin Zan, Christine Cordova, Andrea B. Troxel, Marissa Barbaro, Joshua S. Silverman, Matija Snuderl, David Zagzag, Douglas Kondziolka, John G. Golfinos, Andrew S. Chi, Erik P. Sulman
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 680–686.
https://doi.org/10.1158/1078-0432.CCR-23-2533
Published: 16 February 2024
View article titled, Evaluation of the SSTR2-targeted Radiopharmaceutical <sup>177</sup>Lu-DOTATATE and SSTR2-specific <sup>68</sup>Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma
Open the PDF for Evaluation of the SSTR2-targeted Radiopharmaceutical <sup>177</sup>Lu-DOTATATE and SSTR2-specific <sup>68</sup>Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

Giselle Saulnier-Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacqueline M. Kraveka, William Ferguson, Peter Carmeliet, A. De Deene, Lore Gijsen, Rakesh K. Jain
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18): 3950–3957.
https://doi.org/10.1158/1078-0432.CCR-22-1169
Published: 15 September 2022
View article titled, A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma
Open the PDF for A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma in another window
Includes: Supplementary data
Journal Articles

DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

Kayla Guidry, Varshini Vasudevaraja, Kristen Labbe, Hussein Mohamed, Jonathan Serrano, Brett W. Guidry, Michael DeLorenzo, Hua Zhang, Jiehui Deng, Soumyadip Sahu, Christina Almonte, Andre L. Moreira, Aristotelis Tsirigos, Thales Papagiannakopoulos, Harvey Pass, Matija Snuderl, Kwok-Kin Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17): 3824–3835.
https://doi.org/10.1158/1078-0432.CCR-22-0391
Published: 01 September 2022
View article titled, DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
Open the PDF for DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome in another window
Includes: Supplementary data
Journal Articles

Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements

Theodore Vougiouklakis, Kelsey Zhu, Varshini Vasudevaraja, Jonathan Serrano, Guomiao Shen, Rebecca L. Linn, Xiaojun Feng, Sarah Chiang, Julieta E. Barroeta, Kristen M. Thomas, Lauren E. Schwartz, Pratibha S. Shukla, Anais Malpica, Esther Oliva, Paolo Cotzia, Deborah F. DeLair, Matija Snuderl, George Jour
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1724–1733.
https://doi.org/10.1158/1078-0432.CCR-21-3394
Published: 14 April 2022
View article titled, Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent <em>TERT</em> Rearrangements
Open the PDF for Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent <em>TERT</em> Rearrangements in another window
Includes: Supplementary data
Journal Articles

Abstract IA-19: Machine learning and AI in molecular pathology diagnostics and clinical management of cancer

Matija Snuderl
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (5_Supplement): IA-19.
https://doi.org/10.1158/1557-3265.ADI21-IA-19
Published: 01 March 2021
View article titled, Abstract IA-19: Machine learning and AI in molecular pathology diagnostics and clinical management of cancer
Journal Articles

Abstract A65: Longitudinal detection of TERT-mutant plasma cell-free circulating tumor DNA in newly diagnosed glioblastoma patients

Christine Cordova, Mahrukh M. Syeda, Broderick Corless, Jennifer M. Wiggins, Amie Patel, Sylvia C. Kurz, Malcolm Delara, Zacharia Sawaged, Minerva Utate, Dimitris Placantonakis, John Golfinos, Jessica Schafrick, Joshua S. Silverman, Rajan Jain, Matija Snuderl, David Zagzag, George Karlin-Neumann, David Polsky, Andrew S. Chi
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A65.
https://doi.org/10.1158/1557-3265.LiqBiop20-A65
Published: 01 June 2020
View article titled, Abstract A65: Longitudinal detection of TERT-mutant plasma cell-free circulating tumor DNA in newly diagnosed glioblastoma patients
Journal Articles

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma

Marissa Spino, Sylvia C. Kurz, Luis Chiriboga, Jonathan Serrano, Briana Zeck, Namita Sen, Seema Patel, Guomiao Shen, Varshini Vasudevaraja, Aristotelis Tsirigos, Carter M. Suryadevara, Joshua D. Frenster, Kensuke Tateishi, Hiroaki Wakimoto, Rajan Jain, Howard A. Riina, Theodore P. Nicolaides, Erik P. Sulman, Daniel P. Cahill, John G. Golfinos, Kumiko Isse, Laura R. Saunders, David Zagzag, Dimitris G. Placantonakis, Matija Snuderl, Andrew S. Chi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (4): 1261–1271.
https://doi.org/10.1158/1078-0432.CCR-18-2312
Published: 15 February 2019
View article titled, Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
Open the PDF for Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma in another window
Includes: Supplementary data
Journal Articles

Abstract PR01: A DNA methylation-based classifier for accurate molecular diagnosis of bone sarcomas

Shengyang Wu, Benjamin Cooper, Fang Bu, Christopher Bowman, Jonathan K. Killian, Shiyang Wang, Twana Jackson, Daniel Gorovets, Richard Gorlick, Kristen Thomas, Matthias Karajannis, Matija Snuderl
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2_Supplement): PR01.
https://doi.org/10.1158/1557-3265.SARCOMAS17-PR01
Published: 15 January 2018
View article titled, Abstract PR01: A DNA methylation-based classifier for accurate molecular diagnosis of bone sarcomas
Journal Articles

T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project

Sohil H. Patel, Laila M. Poisson, Daniel J. Brat, Yueren Zhou, Lee Cooper, Matija Snuderl, Cheddhi Thomas, Ana M. Franceschi, Brent Griffith, Adam E. Flanders, John G. Golfinos, Andrew S. Chi, Rajan Jain
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6078–6085.
https://doi.org/10.1158/1078-0432.CCR-17-0560
Published: 12 October 2017
View article titled, T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project
Open the PDF for T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project in another window
Includes: Supplementary data
Journal Articles

Abstract 11: Advancing methylation profiling in neuropathology: Diagnosis and clinical management

Kasthuri S. Kannan, Aristotelis Tsirigos, Jonathan Serrano, Lynn Ann Forrester, Arline Faustin, Cheddhi Thomas, David Capper, Volker Hovestadt, Stefan M. Pfister, David T. W Jones, Martin Sill, Daniel Schrimpf, Andreas von Deimling, Adriana Heguy, Sharon L. Gardner, Jeffrey Allen, Cyrus Hedvat, David Zagzag, Matija Snuderl, Matthias A. Karajannis
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): 11.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-11
Published: 03 January 2016
View article titled, Abstract 11: Advancing methylation profiling in neuropathology: Diagnosis and clinical management
Journal Articles

Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss

Matija Snuderl, April F. Eichler, Keith L. Ligon, Quynh U. Vu, Michael Silver, Rebecca A. Betensky, Azra H. Ligon, Patrick Y. Wen, David N. Louis, A. John Iafrate
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (20): 6430–6437.
https://doi.org/10.1158/1078-0432.CCR-09-0867
Published: 14 October 2009
View article titled, Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss
Open the PDF for Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss in another window